Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans

Detalhes bibliográficos
Ano de defesa: 2013
Autor(a) principal: Silva, Naiara Chaves lattes
Orientador(a): Dias, Amanda Latercia Tranches lattes
Banca de defesa: Silva, Eriques Gonçalves Da, Ariosa, Marília Caixeta Franco
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Alfenas
Programa de Pós-Graduação: Programa de Pós-Graduação em Ciências Farmacêuticas
Departamento: Faculdade de Ciências Farmacêuticas
País: Brasil
Palavras-chave em Português:
Área do conhecimento CNPq:
Link de acesso: https://repositorio.unifal-mg.edu.br/handle/123456789/285
Resumo: Candida spp. has become in recent decades, major causative agents of invasive infections, responsible for high rates of mortality and morbidity. It is believed that the secreted aspartate protease (Sap) is a factor directly associated with infection exerting decisive role in the pathogenicity of Candida spp. and that the exposure to subinibitory concentrations of antifungals may increase the production of Sap and to select resistant isolates. We analyzed isolates of Candida albicans and Candida non-albicans from cases of hospital infection. We evaluated the protein profile of the isolates of Candida spp. by SDS-PAGE. We evaluated also the susceptibility profile of the isolates against antifungals of use conventional in regimens therapeutics (fluconazole and amphotericin B) and newer antifungals that are not yet part of the hospital routine (voriconazole and caspofungin). It was determined the proteolytic activity qualitative and quantitative of Sap and metabolic activity of isolates of C. albicans and Candida non-albicans grown in the presence and absence of subinhibitory concentrations of fluconazole and amphotericin B. Was established the correlation between the tests and, finally, the expression of the SAP2 gene in C. albicans ATCC 64548 and C. krusei ATCC 6258 was evaluated. 100% of the isolates were susceptible to amphotericin B, voriconazole and caspofungin and 89.9% to fluconazole. Two isolates (7.4%) showed susceptibility dose dependent and one (3.7%) showed resistance to fluconazole. In the qualitative analysis of proteolytic activity, 77.7% of the isolates showed activity. The most isolates of C. albicans (50%) and Candida non-albicans (32%) had moderate proteolytic activity. The addition of fluconazole to culture did not promote significant changes in the proteolytic activity of the isolates patterns, while amphotericin B inhibited the growth of C. glabrata ATCC 90030 and C. krusei ATCC 6258. In quantitative analysis, all isolates were active, being that the highest activity was observed in Candida complex “psilosis” 210 (100%) and the lowest in C. albicans 257 (2.44%). The most of the C. albicans isolates (50%) were classified as weakly proteolytic, while Candida non-albicans (53%) as moderately proteolytic. The presence of antifungals in the culture significantly changed the percentage of substrate degradation of the most of isolates. The greatest difference of percentage was observed in C. lusitaniae 286, which in the presence of ¼ IC90 of amphotericin B increased 13.7x regarding to absence of the drug. The quantitative method of determining the proteolytic activity presented greater sensitivity. 63% of the isolates of Candida albicans showed high metabolic activity and 68% of Candida non-albicans had moderate activity. The higher metabolic activity was observed in C. albicans 120 (61.72%) and lowest in C krusei ATCC 6258 (2.35%). The metabolic activity of the most of the isolates was significantly altered. The major difference of percentages was observed in Candida complex “psilosis” 210, which in the presence of ½ IC50 of fluconazole showed reduction of 8x in the metabolic activity regarding to absence of the drug. There was expression of SAP2 only in C. albicans ATCC 64548, which was significantly reduced in the presence of ¼ IC90 of amphotericin B. The Sap activity may be considered a potential factor associated to virulence, once that the isolate that showed the greatest activity showed susceptibility reduced.
id UNIFAL_3b6e7e2607e9ecd21c3f34a145b769e4
oai_identifier_str oai:repositorio.unifal-mg.edu.br:123456789/285
network_acronym_str UNIFAL
network_name_str Repositório Institucional da Universidade Federal de Alfenas - RiUnifal
repository_id_str
spelling Silva, Naiara Chaveshttp://lattes.cnpq.br/3952202974431360Silva, Eriques Gonçalves DaAriosa, Marília Caixeta FrancoDias, Amanda Latercia Trancheshttp://lattes.cnpq.br/75079024737599972015-05-25T19:56:25Z2013-02-15SILVA, Naiara Chaves. Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans. 2013. 102 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2013 .https://repositorio.unifal-mg.edu.br/handle/123456789/285Candida spp. has become in recent decades, major causative agents of invasive infections, responsible for high rates of mortality and morbidity. It is believed that the secreted aspartate protease (Sap) is a factor directly associated with infection exerting decisive role in the pathogenicity of Candida spp. and that the exposure to subinibitory concentrations of antifungals may increase the production of Sap and to select resistant isolates. We analyzed isolates of Candida albicans and Candida non-albicans from cases of hospital infection. We evaluated the protein profile of the isolates of Candida spp. by SDS-PAGE. We evaluated also the susceptibility profile of the isolates against antifungals of use conventional in regimens therapeutics (fluconazole and amphotericin B) and newer antifungals that are not yet part of the hospital routine (voriconazole and caspofungin). It was determined the proteolytic activity qualitative and quantitative of Sap and metabolic activity of isolates of C. albicans and Candida non-albicans grown in the presence and absence of subinhibitory concentrations of fluconazole and amphotericin B. Was established the correlation between the tests and, finally, the expression of the SAP2 gene in C. albicans ATCC 64548 and C. krusei ATCC 6258 was evaluated. 100% of the isolates were susceptible to amphotericin B, voriconazole and caspofungin and 89.9% to fluconazole. Two isolates (7.4%) showed susceptibility dose dependent and one (3.7%) showed resistance to fluconazole. In the qualitative analysis of proteolytic activity, 77.7% of the isolates showed activity. The most isolates of C. albicans (50%) and Candida non-albicans (32%) had moderate proteolytic activity. The addition of fluconazole to culture did not promote significant changes in the proteolytic activity of the isolates patterns, while amphotericin B inhibited the growth of C. glabrata ATCC 90030 and C. krusei ATCC 6258. In quantitative analysis, all isolates were active, being that the highest activity was observed in Candida complex “psilosis” 210 (100%) and the lowest in C. albicans 257 (2.44%). The most of the C. albicans isolates (50%) were classified as weakly proteolytic, while Candida non-albicans (53%) as moderately proteolytic. The presence of antifungals in the culture significantly changed the percentage of substrate degradation of the most of isolates. The greatest difference of percentage was observed in C. lusitaniae 286, which in the presence of ¼ IC90 of amphotericin B increased 13.7x regarding to absence of the drug. The quantitative method of determining the proteolytic activity presented greater sensitivity. 63% of the isolates of Candida albicans showed high metabolic activity and 68% of Candida non-albicans had moderate activity. The higher metabolic activity was observed in C. albicans 120 (61.72%) and lowest in C krusei ATCC 6258 (2.35%). The metabolic activity of the most of the isolates was significantly altered. The major difference of percentages was observed in Candida complex “psilosis” 210, which in the presence of ½ IC50 of fluconazole showed reduction of 8x in the metabolic activity regarding to absence of the drug. There was expression of SAP2 only in C. albicans ATCC 64548, which was significantly reduced in the presence of ¼ IC90 of amphotericin B. The Sap activity may be considered a potential factor associated to virulence, once that the isolate that showed the greatest activity showed susceptibility reduced.Candida spp. se tornaram, nas últimas décadas, importantes agentes causadores de infecções invasivas, responsáveis por altos índices de morbidade e mortalidade. Acredita-se que a aspartato protease secretada (Sap) seja um fator diretamente associado aos processos infecciosos exercendo papel determinante na patogenicidade de Candida spp. e que a exposição a concentrações subinibitórias de antifúngicos, pode aumentar a produção de Sap e selecionar isolados resistentes. Analisaram-se isolados de Candida albicans e Candida não-albicans oriundos de casos de infecção hospitalar. Avaliou-se o perfil proteico destes isolados por eletroforese SDS-PAGE. Avaliou-se, também, o perfil de sensibilidade dos isolados frente a antifúngicos de uso convencional em esquemas terapêuticos (fluconazol e anfotericina B) e a antifúngicos mais novos que ainda não fazem parte das rotinas hospitalares (voriconazol e caspofungina). Determinou-se a atividade proteolítica qualitativa e quantitativa de Sap e atividade metabólica de C. albicans e Candida não-albicans cultivados na presença e ausência de concentrações subinibitórias de fluconazol e anfotericina B. Estabeleceu-se a correlação entre os testes e por fim, avaliou-se a expressão do gene SAP2 em C. albicans ATCC 64548 e C. krusei ATCC 6258. 100% dos isolados foram sensíveis a anfotericina B, voriconazol e caspofungina e 89,9% a fluconazol. Dois isolados (7,4%) apresentaram sensibilidade dependente da dose e um (3,7%) apresentou resistência ao fluconazol. Na análise qualitativa da atividade proteolítica, 77,7% dos isolados apresentaram atividade. A maioria dos isolados de C. albicans (50%) e Candida não-albicans (32%) apresentou atividade proteolítica moderada. A adição de fluconazol ao cultivo não promoveu alterações significativas na atividade proteolítica dos isolados padrões, enquanto anfotericina B inibiu o crescimento de C. glabrata ATCC 90030 e C. krusei ATCC 6258. Na análise quantitativa, todos os isolados se apresentaram ativos, sendo que a maior atividade foi observada em Candida complexo “psilosis” 210 (100%) e a menor em C. albicans 257 (2,44%). A maioria dos isolados de C. albicans (50%) foi classificada como fracamente proteolítica, enquanto Candida não-albicans (53%) como moderadamente proteolítica. A presença de antifúngicos no cultivo alterou significativamente o percentual de degradação da maioria dos isolados. A maior diferença de percentual foi observada em C. lusitaniae 286, que na presença de ¼ da IC90 de anfotericina B aumentou 13,7x em relação à ausência do fármaco. O método quantitativo de determinação da atividade proteolítica apresentou maior sensibilidade. 63% dos isolados de C. albicans apresentaram alta atividade metabólica e 68% de Candida não-albicans, atividade moderada. A maior atividade metabólica foi observada em C. albicans 120 (61,72%) e a menor em C krusei ATCC 6258 (2,35%). A atividade metabólica da maioria dos isolados foi significativamente alterada. A maior diferença de percentual foi observada em Candida complexo “psilosis” 210, que na presença de ½ da IC50 de fluconazol apresentou redução de 8x na atividade metabólica em relação à ausência do fármaco. Houve expressão de SAP2 apenas em C. albicans ATCC 64548, que foi reduzida significativamente na presença de ¼ da IC90 de anfotericina B. A atividade de Sap pode ser considerada um fator potencial associado à virulência, uma vez que o isolado que apresentou a maior atividade apresentou sensibilidade antifúngica reduzida.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESapplication/pdfporUniversidade Federal de AlfenasPrograma de Pós-Graduação em Ciências FarmacêuticasUNIFAL-MGBrasilFaculdade de Ciências Farmacêuticasinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/4.0/Fatores de virulênciaCandida albicansAspartil proteasesProteóliseAntifúngicosCIENCIAS BIOLOGICAS::MICROBIOLOGIAAnálise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicansinfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/publishedVersion-6425845155986244297600600600-38545834699762208122075167498588264571reponame:Repositório Institucional da Universidade Federal de Alfenas - RiUnifalinstname:Universidade Federal de Alfenas (UNIFAL)instacron:UNIFALSilva, Naiara ChavesLICENSElicense.txtlicense.txttext/plain; charset=utf-81987https://repositorio.unifal-mg.edu.br/bitstreams/7d244e24-121e-4c74-bd0a-0fb74090c5eb/download31555718c4fc75849dd08f27935d4f6bMD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849https://repositorio.unifal-mg.edu.br/bitstreams/d36757a7-3494-498f-b900-add4fd8116cd/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-818695https://repositorio.unifal-mg.edu.br/bitstreams/542a7b74-7770-4c5f-86f4-e5792b99a624/download706fa86f01594bbd4ec888ac35076615MD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-823148https://repositorio.unifal-mg.edu.br/bitstreams/f7182a80-13a6-4f98-920a-26536edd77c5/download9da0b6dfac957114c6a7714714b86306MD54ORIGINALDissertação Naiara Chaves Silva.pdfDissertação Naiara Chaves Silva.pdfapplication/pdf1437186https://repositorio.unifal-mg.edu.br/bitstreams/da719eef-c47b-49a0-9c8b-92741a5e755c/download05942cf45f11da91bee2911cee6a4023MD55TEXTDissertação Naiara Chaves Silva.pdf.txtDissertação Naiara Chaves Silva.pdf.txtExtracted texttext/plain102698https://repositorio.unifal-mg.edu.br/bitstreams/8d94468f-8d98-4414-8cfc-e9ead99ffa3d/download65e0961449b1d32ed1addcd52db61473MD58THUMBNAILDissertação Naiara Chaves Silva.pdf.jpgDissertação Naiara Chaves Silva.pdf.jpgGenerated Thumbnailimage/jpeg2631https://repositorio.unifal-mg.edu.br/bitstreams/92541084-020a-4323-94eb-a2d56af6a401/downloade8b502d90aef76da7674767fd665c134MD57123456789/2852026-01-07 14:42:27.068http://creativecommons.org/licenses/by-nc-nd/4.0/open.accessoai:repositorio.unifal-mg.edu.br:123456789/285https://repositorio.unifal-mg.edu.brRepositório InstitucionalPUBhttps://bdtd.unifal-mg.edu.br:8443/oai/requestrepositorio@unifal-mg.edu.bropendoar:2026-01-07T17:42:27Repositório Institucional da Universidade Federal de Alfenas - RiUnifal - Universidade Federal de Alfenas (UNIFAL)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
dc.title.pt-BR.fl_str_mv Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans
title Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans
spellingShingle Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans
Silva, Naiara Chaves
Fatores de virulência
Candida albicans
Aspartil proteases
Proteólise
Antifúngicos
CIENCIAS BIOLOGICAS::MICROBIOLOGIA
title_short Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans
title_full Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans
title_fullStr Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans
title_full_unstemmed Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans
title_sort Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans
author Silva, Naiara Chaves
author_facet Silva, Naiara Chaves
author_role author
dc.contributor.author.fl_str_mv Silva, Naiara Chaves
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/3952202974431360
dc.contributor.referee1.fl_str_mv Silva, Eriques Gonçalves Da
dc.contributor.referee2.fl_str_mv Ariosa, Marília Caixeta Franco
dc.contributor.advisor1.fl_str_mv Dias, Amanda Latercia Tranches
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/7507902473759997
contributor_str_mv Silva, Eriques Gonçalves Da
Ariosa, Marília Caixeta Franco
Dias, Amanda Latercia Tranches
dc.subject.por.fl_str_mv Fatores de virulência
Candida albicans
Aspartil proteases
Proteólise
Antifúngicos
topic Fatores de virulência
Candida albicans
Aspartil proteases
Proteólise
Antifúngicos
CIENCIAS BIOLOGICAS::MICROBIOLOGIA
dc.subject.cnpq.fl_str_mv CIENCIAS BIOLOGICAS::MICROBIOLOGIA
description Candida spp. has become in recent decades, major causative agents of invasive infections, responsible for high rates of mortality and morbidity. It is believed that the secreted aspartate protease (Sap) is a factor directly associated with infection exerting decisive role in the pathogenicity of Candida spp. and that the exposure to subinibitory concentrations of antifungals may increase the production of Sap and to select resistant isolates. We analyzed isolates of Candida albicans and Candida non-albicans from cases of hospital infection. We evaluated the protein profile of the isolates of Candida spp. by SDS-PAGE. We evaluated also the susceptibility profile of the isolates against antifungals of use conventional in regimens therapeutics (fluconazole and amphotericin B) and newer antifungals that are not yet part of the hospital routine (voriconazole and caspofungin). It was determined the proteolytic activity qualitative and quantitative of Sap and metabolic activity of isolates of C. albicans and Candida non-albicans grown in the presence and absence of subinhibitory concentrations of fluconazole and amphotericin B. Was established the correlation between the tests and, finally, the expression of the SAP2 gene in C. albicans ATCC 64548 and C. krusei ATCC 6258 was evaluated. 100% of the isolates were susceptible to amphotericin B, voriconazole and caspofungin and 89.9% to fluconazole. Two isolates (7.4%) showed susceptibility dose dependent and one (3.7%) showed resistance to fluconazole. In the qualitative analysis of proteolytic activity, 77.7% of the isolates showed activity. The most isolates of C. albicans (50%) and Candida non-albicans (32%) had moderate proteolytic activity. The addition of fluconazole to culture did not promote significant changes in the proteolytic activity of the isolates patterns, while amphotericin B inhibited the growth of C. glabrata ATCC 90030 and C. krusei ATCC 6258. In quantitative analysis, all isolates were active, being that the highest activity was observed in Candida complex “psilosis” 210 (100%) and the lowest in C. albicans 257 (2.44%). The most of the C. albicans isolates (50%) were classified as weakly proteolytic, while Candida non-albicans (53%) as moderately proteolytic. The presence of antifungals in the culture significantly changed the percentage of substrate degradation of the most of isolates. The greatest difference of percentage was observed in C. lusitaniae 286, which in the presence of ¼ IC90 of amphotericin B increased 13.7x regarding to absence of the drug. The quantitative method of determining the proteolytic activity presented greater sensitivity. 63% of the isolates of Candida albicans showed high metabolic activity and 68% of Candida non-albicans had moderate activity. The higher metabolic activity was observed in C. albicans 120 (61.72%) and lowest in C krusei ATCC 6258 (2.35%). The metabolic activity of the most of the isolates was significantly altered. The major difference of percentages was observed in Candida complex “psilosis” 210, which in the presence of ½ IC50 of fluconazole showed reduction of 8x in the metabolic activity regarding to absence of the drug. There was expression of SAP2 only in C. albicans ATCC 64548, which was significantly reduced in the presence of ¼ IC90 of amphotericin B. The Sap activity may be considered a potential factor associated to virulence, once that the isolate that showed the greatest activity showed susceptibility reduced.
publishDate 2013
dc.date.issued.fl_str_mv 2013-02-15
dc.date.accessioned.fl_str_mv 2015-05-25T19:56:25Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv SILVA, Naiara Chaves. Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans. 2013. 102 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2013 .
dc.identifier.uri.fl_str_mv https://repositorio.unifal-mg.edu.br/handle/123456789/285
identifier_str_mv SILVA, Naiara Chaves. Análise de aspartato protease (sap) como fator associado à virulência de linhagens de Candida albicans e Candida não-albicans. 2013. 102 f. Dissertação (Mestrado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2013 .
url https://repositorio.unifal-mg.edu.br/handle/123456789/285
dc.language.iso.fl_str_mv por
language por
dc.relation.department.fl_str_mv -6425845155986244297
dc.relation.confidence.fl_str_mv 600
600
600
dc.relation.cnpq.fl_str_mv -3854583469976220812
dc.relation.sponsorship.fl_str_mv 2075167498588264571
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Alfenas
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências Farmacêuticas
dc.publisher.initials.fl_str_mv UNIFAL-MG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade Federal de Alfenas
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal de Alfenas - RiUnifal
instname:Universidade Federal de Alfenas (UNIFAL)
instacron:UNIFAL
instname_str Universidade Federal de Alfenas (UNIFAL)
instacron_str UNIFAL
institution UNIFAL
reponame_str Repositório Institucional da Universidade Federal de Alfenas - RiUnifal
collection Repositório Institucional da Universidade Federal de Alfenas - RiUnifal
bitstream.url.fl_str_mv https://repositorio.unifal-mg.edu.br/bitstreams/7d244e24-121e-4c74-bd0a-0fb74090c5eb/download
https://repositorio.unifal-mg.edu.br/bitstreams/d36757a7-3494-498f-b900-add4fd8116cd/download
https://repositorio.unifal-mg.edu.br/bitstreams/542a7b74-7770-4c5f-86f4-e5792b99a624/download
https://repositorio.unifal-mg.edu.br/bitstreams/f7182a80-13a6-4f98-920a-26536edd77c5/download
https://repositorio.unifal-mg.edu.br/bitstreams/da719eef-c47b-49a0-9c8b-92741a5e755c/download
https://repositorio.unifal-mg.edu.br/bitstreams/8d94468f-8d98-4414-8cfc-e9ead99ffa3d/download
https://repositorio.unifal-mg.edu.br/bitstreams/92541084-020a-4323-94eb-a2d56af6a401/download
bitstream.checksum.fl_str_mv 31555718c4fc75849dd08f27935d4f6b
4afdbb8c545fd630ea7db775da747b2f
706fa86f01594bbd4ec888ac35076615
9da0b6dfac957114c6a7714714b86306
05942cf45f11da91bee2911cee6a4023
65e0961449b1d32ed1addcd52db61473
e8b502d90aef76da7674767fd665c134
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da Universidade Federal de Alfenas - RiUnifal - Universidade Federal de Alfenas (UNIFAL)
repository.mail.fl_str_mv repositorio@unifal-mg.edu.br
_version_ 1859830899689914368